Prothena Corporation plc (PRTA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 10:16AM EDT. Market open.
| Previous Close | 20.56 |
| Open | 20.26 |
| Bid | 19.73 x 100 |
| Ask | 20.05 x 100 |
| Day's Range | 19.65 - 20.26 |
| 52 Week Range | 19.65 - 79.65 |
| Volume | |
| Avg. Volume | 657,135 |
| Market Cap | 1.07B |
| Beta (5Y Monthly) | 0.24 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
DUBLIN, April 15, 2024--Prothena today announced a publication related to the mechanism of action, pharmacological characteristics, and clinical utility of birtamimab.
- Business Wire
Prothena to Participate in Upcoming Healthcare Conferences
DUBLIN, March 05, 2024--Prothena today announced that members of its senior management team will participate in two upcoming investor conferences in March.
- Business Wire
Prothena Appoints David Ford to Newly Created Chief People Officer Position
DUBLIN, March 04, 2024--Prothena today announced that it has named David Ford to a newly created position of Chief People Officer.
© 2024 Yahoo. All rights reserved.